000 | 01323 a2200409 4500 | ||
---|---|---|---|
005 | 20250511204701.0 | ||
264 | 0 | _c19920421 | |
008 | 199204s 0 0 eng d | ||
022 | _a0174-4879 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGonzález-Martin, G | |
245 | 0 | 0 |
_aHeparin-induced hyperkalemia: a prospective study. _h[electronic resource] |
260 |
_bInternational journal of clinical pharmacology, therapy, and toxicology _cNov 1991 |
||
300 |
_a446-50 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aChile |
650 | 0 | 4 | _aDiabetes Complications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeparin _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperkalemia _xchemically induced |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aThromboembolism _xprevention & control |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aDíaz-Molinas, M S | |
700 | 1 | _aMartínez, A M | |
700 | 1 | _aOrtiz, M | |
773 | 0 |
_tInternational journal of clinical pharmacology, therapy, and toxicology _gvol. 29 _gno. 11 _gp. 446-50 |
|
999 |
_c1806619 _d1806619 |